Insulin: Preliminary Phase I/II data

Preliminary data from a double-blind, U.K. Phase I/II trial in 23 healthy volunteers showed that subcutaneous SBS-1000 was bioequivalent to Humulin R rapidly acting recombinant human insulin injection...